Citation Impact
Citing Papers
Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol
1996
Relationship between C‐reactive protein and visceral adipose tissue in healthy Japanese subjects
2004
Severity of diabetic microvascular complications is associated with a low soluble RAGE level
2008
Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients
2008
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
2007
Role of oxidatively modified LDL in atherosclerosis
1990
Wearable biosensors for healthcare monitoring
2019 Standout
The biology of RAGE and its ligands: Uncovering mechanisms at the heart of diabetes and its complications
2007
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
1994
Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study
2009
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Antioxidants and atherosclerosis: A current assessment
1991
Minimally modified low density lipoprotein is biologically active in vivo in mice.
1991
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Role of oxidized low density lipoprotein in atherogenesis
1992
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
1997 Standout
Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.
1993
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
1990
Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60
1988
Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
1995 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
1996
Lipoprotein oxidation and cytotoxicity: Effect of probucol on streptozotocin-treated rats
1988
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis
1998 StandoutNature
Platelet Activation and Atherothrombosis
2007 Standout
Structure-antioxidant activity relationships of flavonoids and phenolic acids
1996 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Binding of Antibodies to the Extractable Nuclear Antigens SS-A/Ro and SS-B/La Is Induced on the Surface of Human Keratinocytes by Ultraviolet Light (UVL): Implications for the Pathogenesis of Photosensitive Cutaneous Lupus
1990
A graphene-based electrochemical device with thermoresponsive microneedles for diabetes monitoring and therapy
2016 Standout
Platelets in inflammation and atherogenesis
2005 Standout
The immune response in atherosclerosis: a double-edged sword
2006 Standout
Modification of human serum low density lipoprotein by oxidation — Characterization and pathophysiological implications
1987
Oxidized LDL-Induced Injury and Apoptosis in Atherosclerosis Potential Roles for Oxysterols
2001
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
1998 Standout
Type 1 diabetes
2013 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Oxidative stress mediates cell surface expression of SS-A/Ro antigen on keratinocytes
2002 StandoutNobel
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Origin and physiological roles of inflammation
2008 StandoutNature
Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins
1990 Nature
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
The role of oxidized lipoproteins in atherogenesis
1996
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells
1991
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
1995 Standout
Atherosclerosis
2001 Standout
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Role of oxidized low density lipoprotein in atherogenesis.
1991 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Homocysteine and Atherothrombosis
1998 Standout
Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages
1997
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis
2010
Cell Biology of the Glomerular Podocyte
2003 Standout
Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro.
1993
Accumulation of triacylglycerol in cultured rat hepatocytes is increased by ethanol and by insulin and dexamethasone
1983
Antioxidant properties of phenolic compounds
1997 Standout
Platelet Degranulation Is Associated With Progression of Intima-Media Thickness of the Common Carotid Artery in Patients With Diabetes Mellitus Type 2
2005
Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.
1991
Advanced Glycation End Products
2006 Standout
7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein.
1994
Alternative splicing of the murine receptor for advanced glycation end‐products (RAGE) gene
2009
Atherosclerosis: Basic Mechanisms
1995 Standout
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
2017
Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.
1991
Antisense to LOX-1 Inhibits Oxidized LDL–Mediated Upregulation of Monocyte Chemoattractant Protein-1 and Monocyte Adhesion to Human Coronary Artery Endothelial Cells
2000 Standout
Oxidation of low-density lipoprotein by copper and iron in phosphate buffer
1991
Cardiovascular Disease Risk Factors in Youth With Diabetes Mellitus
2014
[1] Role of free radicals and catalytic metal ions in human disease: An overview
1990 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.
1990
The Role of Oxidatively Modified Lipoproteins in Lipid Nephropathy
1997
Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex.
1991
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Identification, classification, and expression of RAGE gene splice variants
2007
Probucol prevents oxidative injury to endothelial cells.
1991
Why are low-density lipoproteins atherogenic?
1994
Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL.
1994
Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein.
1991
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health Monitoring
2017 Standout
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes
2010
Increased Monocytic Activity and Biomarkers of Inflammation in Patients With Type 1 Diabetes
2006
Type 1 Diabetes and Coronary Artery Disease
2006
Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes
2011
Mechanisms of Diabetic Complications
2013 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins.
1994
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase.
1990 Standout
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Antioxidant and redox regulation of gene transcription
1996 Standout
Limited Joint Mobility in Diabetes and Ageing: Recent Advances in Pathogenesis and Therapy
2010
Association of NAD(P)H Oxidase p22 phox Gene Variation With Advanced Carotid Atherosclerosis in Japanese Type 2 Diabetes
2003
A review of dipeptidyl peptidase‐4 inhibitors. Hot topics from randomized controlled trials
2018
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity.
1989
Antiinflammatory Properties of HDL
2004 Standout
Circulating Biomarkers of Collagen Metabolism in Cardiac Diseases
2010
Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications
2009
Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol.
1994
Works of Keisuke Kosugi being referenced
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
2015
Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes
2008
Antiplatelet Drugs Attenuate Progression of Carotid Intima-Media Thickness in Subjects with Type 2 Diabetes
2000
α-Glucosidase inhibitor reduces the progression of carotid intima-media thickness
2004
Role of Activated Renin-Angiotensin System in Myocardial Fibrosis and Left Ventricular Diastolic Dysfunction in Diabetic Patients Reversal by Chronic Angiotensin II Type 1A Receptor Blockade
2007
Regulatory Mechanism of Ketogenesis by Glucagon and Insulin in Isolated and Cultured Hepatocytes1
1982
Elevated C-Reactive Protein Associates With Early-Stage Carotid Atherosclerosis in Young Subjects With Type 1 Diabetes
2002
Evaluation of a Minimally Invasive System for Measuring Glucose Area under the Curve during Oral Glucose Tolerance Tests: Usefulness of Sweat Monitoring for Precise Measurement
2013
Decreased Endogenous Secretory Advanced Glycation End Product Receptor in Type 1 Diabetic Patients
2005
Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)
2016
Toxicity of oxidized low‐density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle
1987